Latest news
Elutia Inc. (NASDAQ: ELUT) faces Nasdaq minimum bid price deficiency - Stock TitanStock Titan · Fri, 07 Aug 2026 20:16:13 GMTBeyond Air (NASDAQ: XAIR) regains compliance, faces 1-year Nasdaq monitor - Stock TitanStock Titan · Thu, 06 Aug 2026 23:41:23 GMTGenprex Regains Nasdaq Compliance, Listing Status Secured - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 21:38:00 GMTVistaGen Granted Nasdaq Extension to Regain Bid Compliance - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 21:06:00 GMTZhengye’s closing bid price met Nasdaq’s $1 floor for 10 business days - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTDestination XL Group (NASDAQ: DXLG) gains extra time to meet Nasdaq bid rules - Stock TitanStock Titan · Wed, 05 Aug 2026 21:07:01 GMTGenprex, Inc. (NASDAQ: GNPX) regains Nasdaq minimum bid compliance - Stock TitanStock Titan · Wed, 05 Aug 2026 20:32:17 GMTVistagen Therapeutics (NASDAQ: VTGN) granted 180-day Nasdaq bid-price extension - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:55 GMT